EOF Price sensitive 19 Feb 2025, 9:40 AM

Appendix 4D and Half Year Accounts

Ecofibre Ltd

Ecofibre reports H1 2025 results

Key points

  • Revenue decreased 8% to $12.8m
  • Net loss reduced 61% to $17.7m
  • Focused on core businesses, reducing costs and debt

Full summary

Ecofibre Limited reported a 61% reduction in net loss for the first half of 2025, despite an 8% decline in revenue. The company continued to focus on its core businesses, reduce operating costs, and restructure debt to improve its financial position. Key highlights include: 1) Decision to sell the Ecofibre Genetics business, 2) Commenced a strategic review of the Ananda Health business, 3) Reduced operating costs by 10% compared to the prior period, 4) Completed a sale and leaseback of properties in the US, enabling repayment of $9m in secured debt, 5) Signed new working capital facilities to improve liquidity, and 6) Restructured existing unsecured loans to extend repayment terms. The company's Ecofibre Advanced Technologies (EAT) business, the key growth engine, delivered a small EBITDA profit in the period with improvements in revenue, gross margin and operating costs. The company also continues to focus on realizing value from its EOF Bio life sciences business.

Sign in for more about this company, including guidance changes and other insights.
Sign in